Table: Green Peptide -2016/17 parent results

BrightPath Biotherapeutics Co

12/05/2017 07:00

May 12 (Reuters)-  
          Green Peptide Co., Ltd.  
          PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                 Year ended      Year ended       Year to     NEXT      
              Mar 31, 2017    Mar 31, 2016   Mar 31, 2018     YEAR      
                 LATEST         YEAR-AGO        COMPANY      COMPANY    
                 RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales          529 mln         822 mln                                
               (-35.6 pct)     (+0.1 pct)                               
  Operating     loss 1.09     loss 988 mln                              
  Recurring     loss 1.09     loss 992 mln                              
  Net           loss 1.11     loss 994 mln                              
  EPS        loss 32.74 yen  loss 35.28 yen                             
  Ann Div          NIL             NIL            NIL                   
  -Q2 Div          NIL             NIL            NIL                   
  -Q4 Div          NIL             NIL            NIL                   
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T 
  ((Tokyo Headline News Desk +813 6441 1812))